Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Friday broker round-up

Fri, 17th Feb 2017 09:19

(ShareCast News) - AstraZeneca: Jefferies reiterates Buy with a target price of 5250p.BT Group: Jefferies reiterates Hold with a target price of 325p.Standard Life: Macquarie reiterates Outperform with a target price of 450p.Cobham: Goldman Sachs reiterates Sell with a target price of 88p.Drax: JPMorgan reiterates Overweight with a target price of 410p.South32: Deutsche Bank reiterates Hold with a target price of 157p.Royal Dutch Shell: UBS reiterates Buy with a target price of 2500p.AstraZeneca: Shore reiterates Sell with a target price of 4525p.Kenmare Resources: Canaccord maintains Buy with a target price of 510p.UNITE Group: Numis reiterates Buy with a target price of 731p.

Related Shares

More News
Today 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of Engla...

Today 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4% *

Today 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the...

Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemi...

Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.